NanoString Technologies, Inc. and Cell Signaling Technology have reached an agreement to use highly validated antibodies from CST in NanoString's 3D BiologyTM Protein Profiling Panels. 3D Biology ...
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced plans to commercially unveil the CosMx™ Spatial ...
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced today the commercial unveiling of its new AtoMx™ Spatial ...
NanoString is accelerating the development of the Digital Spatial Profiling technology with customers via its Technology Access Program. Under the program, customers submit up to 20 FFPE tissue ...
NanoString Technologies, Inc. NSTG recently made significant strides in its translational research business. The company entered into CosMxSpatial Molecular Imager partnerships with three specialty ...
NanoString Technologies, Inc. has announced that it has signed a multi-year, multi-investigator research collaboration with Harvard-affiliated Brigham and Women’s Hospital to accelerate the ...
SINGAPORE--(BUSINESS WIRE)--A*STAR’s Genome Institute of Singapore (GIS), NanoString ® Technologies, Inc. (NASDAQ: NSTG), and Next Level Genomics (NLG), today announced the establishment of a joint ...
NanoString’s GeoMX Digital Spatial Profiler was at the heart of a patent lawsuit filed by 10x Genomics. (NanoString Image) Seattle-based publicly traded biotech company NanoString Technologies said in ...
Inclusion of Abcam validated antibodies in CosMx curated protein panel provides the first high-plex spatial multiomic solution at single-cell and subcellular resolution SEATTLE & CAMBRIDGE, United ...
Wednesday, 10x Genomics Inc TXG won an injunction in its patent litigation against NanoString Technologies Inc NSTG and its German subsidiary regarding CosMx Spatial Molecular Imager instruments. The ...
Scientific instruments maker Bruker will pay about $392.6 million in cash to acquire most of the assets of Nanostring, a provider of research tools for spatial biology and gene expression, Nanostring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results